|
|
|
|
| LEADER |
01920nam a2200337 u 4500 |
| 001 |
EB001839280 |
| 003 |
EBX01000000000000001003269 |
| 005 |
00000000000000.0 |
| 007 |
tu||||||||||||||||||||| |
| 008 |
180702 r ||| eng |
| 020 |
|
|
|a 9789289050401
|
| 100 |
1 |
|
|a Renwick, Matthew J.
|
| 245 |
0 |
0 |
|a Targeting innovation in antibiotic drug discovery and development
|h Elektronische Ressource
|b the need for a one health - one Europe - one world framework
|c Matthew J. Renwick, Victoria Simpkin, Elias Mossialos
|
| 260 |
|
|
|a Copenhagen
|b World Health Organization Regional Office for Europe
|c 2016, 2016
|
| 300 |
|
|
|a 1 PDF file (126 pages)
|b illustrations, portrait
|
| 505 |
0 |
|
|a Includes bibliographical references
|
| 653 |
|
|
|a Drug Discovery
|
| 653 |
|
|
|a Europe
|
| 653 |
|
|
|a Drug Resistance, Microbial
|
| 653 |
|
|
|a Health Planning Guidelines
|
| 653 |
|
|
|a Anti-Bacterial Agents
|
| 700 |
1 |
|
|a Simpkin, Victoria
|e [author]
|
| 700 |
1 |
|
|a Mossialos, Elias
|e [author]
|
| 710 |
2 |
|
|a World Health Organization
|b Regional Office for Europe
|
| 710 |
2 |
|
|a European Observatory on Health Systems and Policies
|
| 041 |
0 |
7 |
|a eng
|2 ISO 639-2
|
| 989 |
|
|
|b NCBI
|a National Center for Biotechnology Information
|
| 490 |
0 |
|
|a Health policy series
|
| 856 |
4 |
0 |
|u https://www.ncbi.nlm.nih.gov/books/NBK447337
|3 Volltext
|n NLM Bookshelf Books
|3 Volltext
|
| 082 |
0 |
|
|a 610
|
| 520 |
|
|
|a Antimicrobial resistance is a global crisis that threatens public health and modern medicine. The discovery and development of novel antibiotic products are critical components in combating it. Many international, European Union and national initiatives address the scientific, regulatory and economic barriers to antibiotic innovation. This study identifies, reviews and critically assesses these initiatives, and provides policy recommendations for improving the global and European agendas for research and development of antibiotics
|